| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 12, 2021 | Mar 15, 2021 | ARTIVION, INC. | VP, Clinical Research | Sell | 48.8 | -1,393 | -0.90% | ✗ | $34.9K |
| Mar 5, 2021 | Mar 10, 2021 | ARTIVION, INC. | VP, Clinical Research | Sell | 52.5 | -205 | -0.13% | ✗ | $5K |
| Feb 23, 2021 | Feb 25, 2021 | ARTIVION, INC. | VP, Clinical Research | Sell | 78.8 | +2,613 | 1.72% | ✗ | $14.3K |
| Dec 15, 2020 | Dec 16, 2020 | ARTIVION, INC. | VP, Clinical Research | Sell | 22.5 | -8,366 | -5.33% | ✗ | $178.6K |
| Mar 12, 2020 | Mar 16, 2020 | ARTIVION, INC. | VP, Clinical Research | Sell | 47.5 | -2,231 | -1.49% | ✗ | $4.7K |
| Mar 5, 2020 | Mar 9, 2020 | ARTIVION, INC. | VP, Clinical Research | Sell | 77.5 | +1,970 | 1.34% | ✗ | $8.7K |
| Feb 21, 2020 | Feb 25, 2020 | ARTIVION, INC. | VP, Clinical Research | Sell | 56.3 | +196 | 0.13% | ✗ | $47.2K |
| Nov 26, 2019 | Nov 27, 2019 | ARTIVION, INC. | VP, Clinical Research | Sell | 22.5 | -7,184 | -4.76% | ✗ | $179.1K |
| May 31, 2019 | Jun 3, 2019 | ARTIVION, INC. | VP, Clinical Research | Sell | 22.5 | -2,000 | -1.40% | ✗ | $57.1K |
| Mar 14, 2019 | Mar 18, 2019 | ARTIVION, INC. | VP, Clinical Research | Sell | 78.8 | +2,624 | 1.87% | ✗ | $13.5K |
| Mar 1, 2019 | Mar 4, 2019 | ARTIVION, INC. | VP, Clinical Research | Sell | 48.8 | -1,087 | -0.78% | ✗ | $32.3K |
| Feb 19, 2019 | Feb 21, 2019 | ARTIVION, INC. | VP, Clinical Research | Sell | 22.5 | -2,358 | -1.67% | ✗ | $68K |
| Aug 30, 2018 | Sep 4, 2018 | ARTIVION, INC. | VP, Clinical Research | Sell | 22.5 | -6,332 | -4.30% | ✗ | $215.9K |
| Mar 5, 2018 | Mar 7, 2018 | ARTIVION, INC. | VP, Clinical Research | Sell | 83.8 | +3,393 | 2.57% | ✗ | $11.6K |
| Feb 19, 2018 | Feb 21, 2018 | ARTIVION, INC. | VP, Clinical Research | Sell | 26.3 | -2,246 | -1.68% | ✗ | $41K |
| Feb 19, 2018 | Feb 21, 2018 | ARTIVION, INC. | VP, Clinical Research | Sell | 46.3 | -1,521 | -1.12% | ✗ | $27.8K |
| Feb 13, 2018 | Feb 15, 2018 | ARTIVION, INC. | VP, Clinical Research | Sell | 22.5 | -9,381 | -8.25% | ✗ | $160.4K |
| Feb 26, 2017 | Feb 28, 2017 | ARTIVION, INC. | VP, Clinical Research | Sell | 42.5 | -3,752 | -3.20% | ✗ | $64.7K |
| Feb 22, 2017 | Feb 24, 2017 | ARTIVION, INC. | VP, Clinical Research | Sell | 22.5 | -11,083 | -8.63% | ✗ | $181.8K |
| Feb 19, 2017 | Feb 22, 2017 | ARTIVION, INC. | VP, Clinical Research | Sell | 83.8 | +12,383 | 2.99% | ✗ | $43.7K |
| Feb 26, 2016 | Mar 1, 2016 | ARTIVION, INC. | VP, Clinical Research | Sell | 52.5 | -416 | -0.42% | ✗ | $4.4K |
| Feb 19, 2016 | Feb 23, 2016 | ARTIVION, INC. | VP, Clinical Research | Sell | 60.0 | +323 | 0.07% | ✗ | $170.8K |
| Feb 12, 2016 | Feb 16, 2016 | ARTIVION, INC. | VP, Clinical Research | Sell | 46.3 | -4,232 | -4.77% | ✗ | $38.3K |